Solara Active Pharma Sciences Balance Sheet
- Market cap
- ₹3,120 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹466.34 – ₹874.40
As of FY25, Solara Active Pharma Sciences had total assets of ₹2,028 crore and borrowings of ₹374 crore, against shareholders' equity of ₹1,524 crore — a debt-to-equity ratio of 0.35.
Solara Active Pharma Sciences balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 1,404 |
| Borrowings | 374 |
| Other liabilities | 250 |
| Total liabilities | 2,028 |
| Fixed assets | 1,092 |
| Capital work in progress | 45 |
| Investments | 468 |
| Other assets | 468 |
| Total assets | 2,028 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹227.26
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Solara Active Pharma Sciences balance sheet — frequently asked questions
What is the total debt of Solara Active Pharma Sciences?
Solara Active Pharma Sciences reported borrowings of ₹374 crore as of FY25.
What is Solara Active Pharma Sciences' debt-to-equity ratio?
Based on the FY25 balance sheet, Solara Active Pharma Sciences' debt-to-equity ratio is 0.35 — borrowings of ₹374 crore against equity capital and reserves of ₹1,524 crore.
What are Solara Active Pharma Sciences' total assets?
Solara Active Pharma Sciences' total assets were ₹2,028 crore as of FY25, including fixed assets of ₹1,092 crore and investments of ₹468 crore.
What is the book value per share of Solara Active Pharma Sciences?
The book value per share of Solara Active Pharma Sciences is ₹227.26, based on the latest reported balance sheet.
Same Data For Peers
Trade Solara Active Pharma Sciences With ATS
Track SOLARA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.